Related Experiment Video
Updated: Jan 29, 2026

Closure of a Patent Foramen Ovale PFO: An Intervention Sequence
Published on: December 23, 2022
Amplatzer patent foramen ovale occluder: safety and efficacy
Raouf Madhkour1, Andreas Wahl1, Fabien Praz1
1a Department of Cardiology , University Hospital of Bern , Bern , Switzerland.
Introduction:
The patent foramen ovale (PFO) is a common anatomical variant in humans (prevalence 25%). Most often asymptomatic, it may engender paradoxically embolic strokes, myocardial infarctions, or visceral or peripheral ischemia. It is causatively related to migraine, positional or exertional hypoxemia with dyspnea, diving incidents, high altitude edema, and sleep apnea. Percutaneous closure of atrial septal defects was first performed in the seventies. A dedicated PFO occluder (Amplatzer PFO Occluder) was first used on 10 September 1997 by Kurt Amplatz and Bernhard Meier. Since, percutaneous PFO closure has evolved into one of the most common and the simplest and safest catheter-based intervention in adult cardiology. Randomized studies have proved its benefit for prevention of recurrent ischemic events (particularly strokes) in patients without competing stroke etiology. There are also supportive clinical data for PFO closure in other situations. Areas covered: The Amplatzer PFO Occluder, the first, most implanted, and best-studied PFO occluder, is reviewed, presenting implantation technique, possible complications, and pertinent scientific data of efficacy and safety. Expert commentary: Percutaneous PFO closure has grown to one of the most common procedures in interventional cardiology. Implantation of the Amplatzer PFO Occluder is simple, safe, and effective.
Insights
Patent foramen ovale (PFO) closure using the Amplatzer device is a safe and effective treatment. This review covers the Amplatzer PFO Occluder, its implantation, and clinical data on efficacy and safety.
Area of Science:
- Interventional Cardiology
- Cardiovascular Medicine
- Medical Device Technology
Background:
- Patent foramen ovale (PFO) affects 25% of humans, potentially causing strokes, heart attacks, and other ischemic events.
- PFO is linked to conditions like migraine, hypoxemia, and sleep apnea.
- Percutaneous closure of atrial septal defects began in the 1970s, with dedicated PFO devices emerging later.
Purpose of the Study:
- To review the Amplatzer PFO Occluder, the first and most widely used device for percutaneous PFO closure.
- To present the implantation technique, potential complications, and scientific evidence regarding the efficacy and safety of the Amplatzer PFO Occluder.
- To highlight the evolution and current status of percutaneous PFO closure in adult cardiology.
Main Methods:
- Review of the Amplatzer PFO Occluder, including its history and development.
- Analysis of implantation techniques and potential complications associated with the device.
- Synthesis of scientific data from randomized studies and clinical experience regarding PFO closure efficacy and safety.
Main Results:
- Percutaneous PFO closure, particularly with the Amplatzer device, has become a common, simple, and safe catheter-based intervention.
- Randomized studies confirm the benefit of PFO closure in preventing recurrent ischemic events, especially strokes, in select patients.
- The Amplatzer PFO Occluder is the most implanted and best-studied device, demonstrating high efficacy and safety.
Conclusions:
- Percutaneous PFO closure is a well-established and highly successful procedure in interventional cardiology.
- The Amplatzer PFO Occluder offers a simple, safe, and effective solution for patients with PFO-related conditions.
- Continued research and clinical data support the expanding role of PFO closure in managing various cardiovascular and neurological conditions.
More Related Videos
09:32Network Analysis of Foramen Ovale Electrode Recordings in Drug-resistant Temporal Lobe Epilepsy Patients
Published on: December 18, 2016
04:53A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
Related Concept Videos
Survey Safety
Self-Efficacy
Household Wiring And Electrical Safety
Dose-Response Relationship: Potency and Efficacy
Hearing
Blind Procedures